Source and scope
This summary is bounded to the recommendations, population and decisions covered by Using Antibiotics Wisely in primary care. Apply it with the current provincial or territorial pathway where implementation differs.
sources for this section:CWC antibiotics
Source-attributed clinical priorities
- Diagnose acute bacterial rhinosinusitis from a persistent, severe or worsening pattern rather than purulent discharge alone.
- Use supportive care for likely viral disease and reserve antibiotics for the source-defined bacterial phenotype.
- Escalate orbital signs, severe frontal headache, neurologic features, facial swelling or immunocompromise.
- Routine sinus imaging does not distinguish uncomplicated viral from bacterial rhinosinusitis.
sources for this section:CWC antibiotics
Practical assessment and management workflow
1
Define symptom duration and whether illness is persistent, severe at onset or worsening after initial improvement.
2
Examine eyes, facial swelling, dentition and neurologic status for complications or an alternative source.
3
Use saline, analgesia and intranasal treatment where appropriate and reserve antibiotics for a bacterial pattern.
4
Review recurrent or chronic disease for allergy, anatomy, dental infection and specialist need.
sources for this section:CWC antibiotics
Safety, red flags and urgent escalation
- Orbital swelling, impaired eye movement, reduced vision or proptosis needs emergency assessment.
- Severe frontal headache, meningism, focal deficit or altered consciousness suggests intracranial spread.
- Avoid repeated broad-spectrum antibiotics without reassessing the diagnosis.
sources for this section:CWC antibiotics
Confirm the local pathway before acting
The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.
sources for this section:CWC antibiotics
Source and implementation boundary
Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:CWC antibiotics
Source documents
Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.
- Choosing Wisely CanadaUsing Antibiotics Wisely in primary careaccessed 2026-08-20view source
continue the learning
From guidance to deliberate practice and evidence
Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.
Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Canada question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.